Dexcom CEO on ‘ treading new ground ’ with G6 glucose monitor

Kevin Sayer sold his first glucose sensor in 1994. More than twenty years later, the chief executive of Dexcom (NSDQ:DXCM) still believes that glucose-monitoring technology can transform the way patients manage their diabetes. This week, Dexcom won FDA approval for its latest continuous glucose monitor. The G6 system is the first of the company’s that does not require a finger-prick for calibration and is also cleared as “fully interoperable” with other medical devices, like insulin pumps and decision support software. “This Gen 6 system brings to fruition all that I envisioned when I first saw a sensor in the 90’s,” Sayer told Drug Delivery Business News.  Get the full story at our sister site, Drug Delivery Business News. The post Dexcom CEO on ‘treading new ground’ with G6 glucose monitor appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Diabetes Food & Drug Administration (FDA) Pharmaceuticals Regulatory/Compliance Wall Street Beat Dexcom Eli Lilly & Co. Insulet tandemdiabetes Source Type: news